Partnering to build enduring
healthcare companies with
operational excellence.
Concordia Healthcare Partners invests in resilient, scalable pharmaceutical businesses across Europe, bringing hands-on operating experience and long-term capital to every partnership.
Our team has successfully guided pharmaceutical businesses through exits to global pharmaceutical groups as well as leading private equity investors, giving us a deep understanding of what drives long-term value.
A specialist pharma
investment firm
Concordia Healthcare Partners is a specialized investment firm based in Athens and London, focused on pharmaceuticals and related services across Europe. Founded by two prominent pharma entrepreneurs with a long-standing history in the international pharmaceutical sector, we bring patient, relationship-driven capital to ambitious healthcare entrepreneurs.
Operator mindset
We have built and exited successful pharmaceutical businesses, and understand the day-to-day operational realities of running pharma companies.
Healthcare focus
We concentrate on pharmaceuticals, specialty pharma, CDMOs and adjacent services where we act as an informed, value-adding partner.
Partnership approach
We offer collaborative, founder-friendly capital, prioritizing long-term value creation over short-term financial engineering.
Growth &
transformational
investments
We focus on growth and transformational investments in small to mid-sized pharma and healthcare companies across Europe, backing teams seeking to scale strong platforms into industry leaders.
We also deploy substantial capital in established and emerging large-scale pharma and healthcare companies through strategic co-investment arrangements with leading institutional partners, leveraging our deep sector expertise and network to participate in significant value-creation opportunities.
Sectors
We invest across pharmaceutical platforms; specialty pharma and niche therapeutics; healthcare services with a pharma nexus; and the infrastructure that supports resilient healthcare businesses.
Situations
Founder- and family-led businesses, succession and growth capital, carve-outs, buy-and-build platforms and companies requiring operational transformation.
What we bring
- Strategic positioning and portfolio shaping in competitive markets.
- M&A support and internationalization, including bolt-ons and new market entry.
- Governance and professionalization to support the next stage of growth.
- Access to an experienced industry network across pharma, healthcare and finance.
Built for pharma
founders and CEOs
Our approach is tailored to pharma founders, families and CEOs who want a partner to help them scale, professionalize and internationalize their businesses without compromising their distinct identity. We work alongside management teams to accelerate growth, strengthen governance and broaden options, while preserving culture and long-term vision.
Collaborative
governance
Board-level support, structured reporting and strategic input, provided without day-to-day operational interference.
Long-term
horizon
Patient, family-backed capital aligned with sustainable value creation, avoiding short-term financial engineering or forced timelines.
Value
beyond capital
Hands-on support with strategy, international expansion, M&A and leadership development, backed by a curated network of sector experts.
Founders
& leadership
Investing across the
pharmaceutical value chain
Pharmaceutical
platforms
Scaled or scalable pharma businesses with robust portfolios, rigorous quality systems and clear room for organic and inorganic growth.
Specialty pharma
and niche therapeutics
Focused companies addressing defined patient, prescriber, or channel needs, where targeted portfolios and highly differentiated capabilities matter.
Healthcare services
with a pharma nexus
Services that enable pharma access, distribution and patient engagement, including market access, commercial support and related offerings.
Supporting
infrastructure
Critical infrastructure and technology-enabled services that support reliable, high-quality pharma development, manufacturing and supply chains, including CDMOs and distribution.
Thoughtfulness
& responsibility
We believe responsible private capital plays a vital role in strengthening healthcare systems, improving access and supporting high-quality care. We back companies dedicated to enhancing patient outcomes, product quality and system efficiency, while operating with transparency and robust governance.
Prioritise product quality, safety and reliability across every enterprise we support.
Promote transparent, fully compliant business practices with clear governance structures.
Support work that protects health, strengthens communities and creates lasting value.
Let's talk
We welcome conversations with pharma and healthcare founders, management teams and co-investors.
